The AGTAG model is designed to calculate the risk of hepatocellular carcinoma (HCC) in the general population. Based on the individual's characteristics, liver function tests, and alpha-fetoprotein (AFP) levels, it provides an assessment of HCC risk for clinical reference.
|
Please note that this model is not applicable to individuals with pre-existing liver diseases or those in the postoperative recovery phase of liver cancer. The calculation results are for reference only. If you have any questions, please consult a professional medical practitioner.